The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overload
Open accessAbstract
The cardiac pathological response to sustained pressure overload involves myocyte hypertrophy and dysfunction along with interstitial changes such as fibrosis and reduced capillary density. These changes are orchestrated by mechanical forces and factors secreted between cells. One such secreted factor is TGF-β, which is generated by and interacts with multiple cell types. Here we have shown that TGF-β suppression in cardiomyocytes was required to protect against maladaptive remodeling and involved noncanonical (non-Smad-related) signaling. Mouse hearts subjected to pressure overload and treated with a TGF-β-neutralizing Ab had suppressed Smad activation in the interstitium but not in myocytes, and noncanonical (TGF-β-activated kinase 1 [TAK1]) activation remained. Although fibrosis was greatly reduced, chamber dysfunction and dilation persisted. Induced myocyte knockdown of TGF-β type 2 receptor (TβR2) blocked all maladaptive responses, inhibiting myocyte and interstitial Smad and TAK1. Myocyte knockdown of TβR1 suppressed myocyte but not interstitial Smad, nor TAK1, modestly reducing fibrosis without improving chamber function or hypertrophy. Only TβR2 knockdown preserved capillary density after pressure overload, enhancing BMP7, a regulator of the endothelial-mesenchymal transition. BMP7 enhancement also was coupled to TAK1 suppression. Thus, myocyte targeting is required to modulate TGF-β in hearts subjected to pressure overload, with noncanonical pathways predominantly affecting the maladaptive hypertrophy/dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005313222203 · Cited by 5,699
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Molecular Mechanisms of Myocardial Remodeling
SWYNGHEDAUW, B. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.215 · Cited by 1,460
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Hein, S., Arnon, E., Kostin, S., Schönburg, M., Elsässer, A., Polyakova, V., Bauer, E. P., Klövekorn, W.-P., & Schaper, J. (2003) · Circulation · doi:10.1161/01.cir.0000051865.66123.b7 · Cited by 1,102
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Sano, M., Minamino, T., Toko, H., Miyauchi, H., Orimo, M., Qin, Y., Akazawa, H., Tateno, K., Kayama, Y., Harada, M., et al. (2007) · Nature · doi:10.1038/nature05602 · Cited by 905
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D., Ren, S., Rodriguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 903
Self-citationPacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., & Kass, D. A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.138 · Cited by 734
Self-citationCohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1536 · Cited by 669
Leask, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.217737 · Cited by 667
TGF-β Receptor Type II Deficiency Results in Defects of Yolk Sac Hematopoiesis and Vasculogenesis
Oshima, M., Oshima, H., & Taketo, M. M. (1996) · Developmental Biology · doi:10.1006/dbio.1996.0259 · Cited by 645
Kuwahara, F., Kai, H., Tokuda, K., Kai, M., Takeshita, A., Egashira, K., & Imaizumi, T. (2002) · Circulation · doi:10.1161/01.cir.0000020689.12472.e0 · Cited by 609
TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-β
Yamashita, M., Fatyol, K., Jin, C., Wang, X., Liu, Z., & Zhang, Y. E. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.002 · Cited by 559
The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner
Sorrentino, A., Thakur, N., Grimsby, S., Marcusson, A., von Bulow, V., Schuster, N., Zhang, S., Heldin, C.-H., & Landström, M. (2008) · Nature Cell Biology · doi:10.1038/ncb1780 · Cited by 553
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Manabe, I., Shindo, T., & Nagai, R. (2002) · Circulation Research · doi:10.1161/01.res.0000046452.67724.b8 · Cited by 512
Ubiquitin-mediated activation of TAK1 and IKK
Adhikari, A., Xu, M., & Chen, Z. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210413 · Cited by 457
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14190 · Cited by 426
Tackling heart failure in the twenty-first century
Mudd, J. O., & Kass, D. A. (2008) · Nature · doi:10.1038/nature06798 · Cited by 406
Self-citationTGF‐β signaling: A tale of two responses
Rahimi, R. A., & Leof, E. B. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21501 · Cited by 371
TGF-β1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II
Schultz, J. E. J., Witt, S. A., Glascock, B. J., Nieman, M. L., Reiser, P. J., Nix, S. L., Kimball, T. R., & Doetschman, T. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214190 · Cited by 351
Zhang, D., Gaussin, V., Taffet, G. E., Belaguli, N. S., Yamada, M., Schwartz, R. J., Michael, L. H., Overbeek, P. A., & Schneider, M. D. (2000) · Nature Medicine · doi:10.1038/75037 · Cited by 337
Self-citationThe in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy
Liao, P., Georgakopoulos, D., Kovacs, A., Zheng, M., Lerner, D., Pu, H., Saffitz, J., Chien, K., Xiao, R.-P., Kass, D. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211086598 · Cited by 333
Self-citationIntramyocardial Fibroblast Myocyte Communication
Kakkar, R., & Lee, R. T. (2010) · Circulation Research · doi:10.1161/circresaha.109.207456 · Cited by 333
Origin of Cardiac Fibroblasts and the Role of Periostin
Snider, P., Standley, K. N., Wang, J., Azhar, M., Doetschman, T., & Conway, S. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.201400 · Cited by 302
Dasch, J. R., Pace, D. R., Waegell, W., Inenaga, D., & Ellingsworth, L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.5.1536 · Cited by 293
Emerging role of bone morphogenetic proteins in angiogenesis
David, L., Feige, J.-J., & Bailly, S. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.05.001 · Cited by 282
Li, R.-K., Li, G., Mickle, D. A. G., Weisel, R. D., Merante, F., Luss, H., Rao, V., Christakis, G. T., & Williams, W. G. (1997) · Circulation · doi:10.1161/01.cir.96.3.874 · Cited by 211
Koitabashi, N., Bedja, D., Zaiman, A. L., Pinto, Y. M., Zhang, M., Gabrielson, K. L., Takimoto, E., & Kass, D. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.198416 · Cited by 203
Self-citationFrantz, S., Hu, K., Adamek, A., Wolf, J., Sallam, A., KG Maier, S., Lonning, S., Ling, H., Ertl, G., & Bauersachs, J. (2008) · Basic Research in Cardiology · doi:10.1007/s00395-008-0739-7 · Cited by 201
Takahashi, N., Calderone, A., Izzo, N. J., Mäki, T. M., Marsh, J. D., & Colucci, W. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117485 · Cited by 196
Koitabashi, N., Aiba, T., Hesketh, G. G., Rowell, J., Zhang, M., Takimoto, E., Tomaselli, G. F., & Kass, D. A. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2009.11.015 · Cited by 177
Self-citationThe complex pattern of SMAD signaling in the cardiovascular system☆
EULERTAIMOR, G., & HEGER, J. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.07.007 · Cited by 165
The MEK Pathway Is Required for Stimulation of p21WAF1/CIP1 by Transforming Growth Factor-β
Hu, P. P.-C., Shen, X., Huang, D., Liu, Y. I., Counter, C. M., & Wang, X.-F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35381 · Cited by 157
Nagayama, T., Hsu, S., Zhang, M., Koitabashi, N., Bedja, D., Gabrielson, K. L., Takimoto, E., & Kass, D. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.069 · Cited by 150
Self-citationTargeted Disruption of Smad4 in Cardiomyocytes Results in Cardiac Hypertrophy and Heart Failure
Wang, J., Xu, N., Feng, X., Hou, N., Zhang, J., Cheng, X., Chen, Y., Zhang, Y., & Yang, X. Y. (2005) · Circulation Research · doi:10.1161/01.res.0000185833.42544.06 · Cited by 146
The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis
Yoon, P. O., Lee, M.-A., Cha, H., Jeong, M. H., Kim, J., Jang, S. P., Choi, B. Y., Jeong, D., Yang, D. K., Hajjar, R. J., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.04.010 · Cited by 142
Bone Morphogenetic Protein-7 Signals Opposing Transforming Growth Factor β in Mesangial Cells
Wang, S., & Hirschberg, R. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311998200 · Cited by 135
Koitabashi, N., Arai, M., Kogure, S., Niwano, K., Watanabe, A., Aoki, Y., Maeno, T., Nishida, T., Kubota, S., Takigawa, M., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.106.077537 · Cited by 132
Self-citationMatsumoto-Ida, M., Takimoto, Y., Aoyama, T., Akao, M., Takeda, T., & Kita, T. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00186.2005 · Cited by 119
Divakaran, V. G., Adrogue, J. V., Ishiyama, M., Entman, M. L., Haudek, S. B., Sivasubramanian, N., & Mann, D. L. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.823070 · Cited by 112
The TGFβ superfamily in myocardium: Ligands, receptors, transduction, and function
BRAND, T., & Schneider, M. D. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80003-x · Cited by 98
TGF-β1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation
Lim, J. H., PARK, S., PARK, S., HWANG, H., PARK, E., Kim, J., KIM, J., PARK, S., & PARK, S. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.06.016 · Cited by 95
Sakata, Y., Chancey, A. L., Divakaran, V. G., Sekiguchi, K., Sivasubramanian, N., & Mann, D. L. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0689-5 · Cited by 92
Vahebi, S., Ota, A., Li, M., Warren, C. M., de Tombe, P. P., Wang, Y., & Solaro, R. J. (2007) · Circulation Research · doi:10.1161/01.res.0000258116.60404.ad · Cited by 89
Maladaptive Growth in the Failing Heart: The Cardiomyopathy of Overload
Katz, A. M. (2002) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1020604623427 · Cited by 88
MATSUI, Y. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.012 · Cited by 78
Cited by
Mechanisms of physiological and pathological cardiac hypertrophy
Nakamura, M., & Sadoshima, J. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0007-y · Cited by 1,658
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
The pathogenesis of cardiac fibrosis
Kong, P., Christia, P., & Frangogiannis, N. G. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1349-6 · Cited by 1,567
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94753 · Cited by 905
Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities
Frangogiannis, N. G. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.07.001 · Cited by 841
Metadata
- Authors
- Koitabashi, N., Danner, T., Zaiman, A. L., Pinto, Y. M., Rowell, J., Mankowski, J., Zhang, D., Nakamura, T., Takimoto, E., & Kass, D. A.
- Venue
- Journal of Clinical Investigation
- Published
- 2011-06-01
- Volume
- 121
- Issue
- 6
- Pages
- 2301-2312
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2074156641
- Cited by
- 334
- References
- 49
- FWCI
- 15.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.